Global Cancer Clinical Decision Tools Market Forecast To 2023

The global cancer clinical decision tools market is expected to decline from $0.38 billion in 2019 to $0.35 billion in 2020 at a compound annual growth rate (CAGR) of -7.41%. The decline is mainly due to the COVID-19 outbreak that has deferred treatment for cancer unless the conditions are serious. The market is then expected to recover and reach $0.47 billion in 2023 at a CAGR of 10.23%. The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision tools market. However, the breach of data and privacy of patients is a major challenge in the market.

Cancer decision tools are designed to support the general practitioner’s assessment of patients with potential cancer symptoms. The tools do not change the clinical judgment but give more information that is used to inform patient management decisions. The risk is measured based on reading coded information from the patient record including demographic data, medical history, and symptoms.

Request For A Sample For The Global Cancer Clinical Decision Tools Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3463&type=smp

The global cancer clinical decision tools market is further segmented based on type and geography.
By Type: Risk Assessment Tool (RAT), Qcancer
By End-User: Hospital, Clinics.
By Geography: The global cancer clinical decision tools market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Cancer Clinical Decision Tools Market At:
https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tools-global-market-report-2020-30-covid-19-growth-and-change

Trends In The Cancer Clinical Decision Tools Market
In January 2018, Elsevier, a Netherlands-based information analytics company specialized in science and health, acquired Via Oncology for an undisclosed amount. The acquisition is expected to accelerate Elsevier’s ability to support not only the referential needs of caregivers but also the workflow needs of clinicians. Integrating the decision tools in electronic medical records will help healthcare professionals to make informed decisions. Via Oncology is a Pennsylvania-based company that provides decision support in cancer care management.
Cancer Clinical Decision Tools Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides cancer clinical decision tools market overviews, analyzes and forecasts cancer clinical decision tools market size and growth for the global cancer clinical decision tools market, cancer clinical decision tools market share, cancer clinical decision tools market players, cancer clinical decision tools market size, cancer clinical decision tools market segments and geographies, cancer clinical decision tools market trends, cancer clinical decision tools market drivers and cancer clinical decision tools market restraints, cancer clinical decision tools market’s leading competitors’ revenues, profiles and market shares. The cancer clinical decision tools market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)